The impact of comorbidities on mortality among men and women with COPD: report from the OLIN COPD study

Background: Comorbidities probably contribute to the increased mortality observed among subjects with chronic obstructive pulmonary disease (COPD), but sex differences in the prognostic impact of comorbidities have rarely been evaluated in population-based studies. The aim of this study was to evalu...

Full description

Bibliographic Details
Main Authors: Sami Sawalha, Linnea Hedman, Helena Backman, Nikolai Stenfors, Eva Rönmark, Bo Lundbäck, Anne Lindberg
Format: Article
Language:English
Published: SAGE Publishing 2019-07-01
Series:Therapeutic Advances in Respiratory Disease
Online Access:https://doi.org/10.1177/1753466619860058
id doaj-82b5c5adfeb34ec8bd54d8b00c8ed668
record_format Article
spelling doaj-82b5c5adfeb34ec8bd54d8b00c8ed6682020-11-25T03:24:36ZengSAGE PublishingTherapeutic Advances in Respiratory Disease1753-46662019-07-011310.1177/1753466619860058The impact of comorbidities on mortality among men and women with COPD: report from the OLIN COPD studySami SawalhaLinnea HedmanHelena BackmanNikolai StenforsEva RönmarkBo LundbäckAnne LindbergBackground: Comorbidities probably contribute to the increased mortality observed among subjects with chronic obstructive pulmonary disease (COPD), but sex differences in the prognostic impact of comorbidities have rarely been evaluated in population-based studies. The aim of this study was to evaluate the impact of common comorbidities, cardiovascular disease (CVD), diabetes mellitus (DM), and anxiety/depression (A/D), on mortality among men and women with and without airway obstruction in a population-based study. Methods: All subjects with airway obstruction [forced expiratory volume in 1 second (FEV 1 )/(forced) vital capacity ((F)VC) <0.70, n  = 993] were, together with age- and sex-matched referents, identified after examinations of population-based cohorts in 2002–2004. Spirometric groups: normal lung function (NLF) and COPD (post-bronchodilator FEV 1 /(F)VC <0.70) and additionally, LLN-COPD (FEV 1 /(F)VC <lower limit of normal). Mortality data was collected until December 2015. Results: In COPD, the prevalence of CVD and DM was higher in men, whereas the prevalence of A/D was higher in women. The cumulative mortality was significantly higher in COPD than NLF, and higher in men than women in both groups. Among women with COPD, CVD and A/D but not DM increased the risk of death independent of age, body mass index, smoking habits, and disease severity, whereas among men DM and A/D but not CVD increased the risk for death. When the LLN criterion was applied, the pattern was similar. Conclusion: There were sex-dependent differences regarding the impact of comorbidities on prognosis in COPD. Even though the prevalence of CVD was higher in men, the impact of CVD on mortality was higher in women, and despite higher prevalence of A/D in women, the impact on mortality was similar in both sexes. The reviews of this paper are available via the supplemental material section.https://doi.org/10.1177/1753466619860058
collection DOAJ
language English
format Article
sources DOAJ
author Sami Sawalha
Linnea Hedman
Helena Backman
Nikolai Stenfors
Eva Rönmark
Bo Lundbäck
Anne Lindberg
spellingShingle Sami Sawalha
Linnea Hedman
Helena Backman
Nikolai Stenfors
Eva Rönmark
Bo Lundbäck
Anne Lindberg
The impact of comorbidities on mortality among men and women with COPD: report from the OLIN COPD study
Therapeutic Advances in Respiratory Disease
author_facet Sami Sawalha
Linnea Hedman
Helena Backman
Nikolai Stenfors
Eva Rönmark
Bo Lundbäck
Anne Lindberg
author_sort Sami Sawalha
title The impact of comorbidities on mortality among men and women with COPD: report from the OLIN COPD study
title_short The impact of comorbidities on mortality among men and women with COPD: report from the OLIN COPD study
title_full The impact of comorbidities on mortality among men and women with COPD: report from the OLIN COPD study
title_fullStr The impact of comorbidities on mortality among men and women with COPD: report from the OLIN COPD study
title_full_unstemmed The impact of comorbidities on mortality among men and women with COPD: report from the OLIN COPD study
title_sort impact of comorbidities on mortality among men and women with copd: report from the olin copd study
publisher SAGE Publishing
series Therapeutic Advances in Respiratory Disease
issn 1753-4666
publishDate 2019-07-01
description Background: Comorbidities probably contribute to the increased mortality observed among subjects with chronic obstructive pulmonary disease (COPD), but sex differences in the prognostic impact of comorbidities have rarely been evaluated in population-based studies. The aim of this study was to evaluate the impact of common comorbidities, cardiovascular disease (CVD), diabetes mellitus (DM), and anxiety/depression (A/D), on mortality among men and women with and without airway obstruction in a population-based study. Methods: All subjects with airway obstruction [forced expiratory volume in 1 second (FEV 1 )/(forced) vital capacity ((F)VC) <0.70, n  = 993] were, together with age- and sex-matched referents, identified after examinations of population-based cohorts in 2002–2004. Spirometric groups: normal lung function (NLF) and COPD (post-bronchodilator FEV 1 /(F)VC <0.70) and additionally, LLN-COPD (FEV 1 /(F)VC <lower limit of normal). Mortality data was collected until December 2015. Results: In COPD, the prevalence of CVD and DM was higher in men, whereas the prevalence of A/D was higher in women. The cumulative mortality was significantly higher in COPD than NLF, and higher in men than women in both groups. Among women with COPD, CVD and A/D but not DM increased the risk of death independent of age, body mass index, smoking habits, and disease severity, whereas among men DM and A/D but not CVD increased the risk for death. When the LLN criterion was applied, the pattern was similar. Conclusion: There were sex-dependent differences regarding the impact of comorbidities on prognosis in COPD. Even though the prevalence of CVD was higher in men, the impact of CVD on mortality was higher in women, and despite higher prevalence of A/D in women, the impact on mortality was similar in both sexes. The reviews of this paper are available via the supplemental material section.
url https://doi.org/10.1177/1753466619860058
work_keys_str_mv AT samisawalha theimpactofcomorbiditiesonmortalityamongmenandwomenwithcopdreportfromtheolincopdstudy
AT linneahedman theimpactofcomorbiditiesonmortalityamongmenandwomenwithcopdreportfromtheolincopdstudy
AT helenabackman theimpactofcomorbiditiesonmortalityamongmenandwomenwithcopdreportfromtheolincopdstudy
AT nikolaistenfors theimpactofcomorbiditiesonmortalityamongmenandwomenwithcopdreportfromtheolincopdstudy
AT evaronmark theimpactofcomorbiditiesonmortalityamongmenandwomenwithcopdreportfromtheolincopdstudy
AT bolundback theimpactofcomorbiditiesonmortalityamongmenandwomenwithcopdreportfromtheolincopdstudy
AT annelindberg theimpactofcomorbiditiesonmortalityamongmenandwomenwithcopdreportfromtheolincopdstudy
AT samisawalha impactofcomorbiditiesonmortalityamongmenandwomenwithcopdreportfromtheolincopdstudy
AT linneahedman impactofcomorbiditiesonmortalityamongmenandwomenwithcopdreportfromtheolincopdstudy
AT helenabackman impactofcomorbiditiesonmortalityamongmenandwomenwithcopdreportfromtheolincopdstudy
AT nikolaistenfors impactofcomorbiditiesonmortalityamongmenandwomenwithcopdreportfromtheolincopdstudy
AT evaronmark impactofcomorbiditiesonmortalityamongmenandwomenwithcopdreportfromtheolincopdstudy
AT bolundback impactofcomorbiditiesonmortalityamongmenandwomenwithcopdreportfromtheolincopdstudy
AT annelindberg impactofcomorbiditiesonmortalityamongmenandwomenwithcopdreportfromtheolincopdstudy
_version_ 1724601226769727488